Shohreh Shahabi Selected Research

Leiomyoma (Uterine Fibroids)

1/2018

Discussing sarcoma risks during informed consent for nonhysterectomy management of fibroids: an unmet need.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shohreh Shahabi Research Topics

Disease

38	Neoplasms (Cancer) 10/2021 - 12/2005
18	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 06/2009
10	Endometrial Neoplasms (Endometrial Cancer) 02/2021 - 03/2007
7	Neoplasm Metastasis (Metastasis) 04/2017 - 07/2014
6	Carcinoma (Carcinomatosis) 11/2018 - 03/2007
6	Breast Neoplasms (Breast Cancer) 05/2018 - 11/2010
6	Margins of Excision 11/2017 - 12/2016
4	Ovarian Epithelial Carcinoma 01/2018 - 12/2005
4	Carcinosarcoma 04/2017 - 03/2007
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2018 - 01/2017
2	Abscess 01/2020 - 05/2002
2	Carcinogenesis 05/2018 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 11/2015
2	Uterine Neoplasms (Uterine Cancer) 12/2016 - 06/2009
2	Endometrioid Carcinoma 07/2014 - 03/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 05/2012
1	Inflammation (Inflammations) 01/2020
1	Leiomyoma (Uterine Fibroids) 01/2018
1	Lymphatic Metastasis 01/2018
1	Circulating Neoplastic Cells 01/2018
1	Smooth Muscle Tumor 01/2018
1	Residual Neoplasm 01/2018
1	Leiomyosarcoma 04/2017
1	Postoperative Pain 01/2017
1	Adenocarcinoma 11/2015
1	Uterine Hemorrhage (Uterine Bleeding) 05/2015
1	Menorrhagia 05/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 05/2015
1	Teratoma (Teratoid Tumor) 10/2014
1	Disease Progression 01/2014
1	Starvation 05/2012
1	Infections 01/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 05/2018 - 12/2005
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2012
6	TubulinIBA 02/2013 - 12/2005
4	Messenger RNA (mRNA)IBA 05/2018 - 07/2010
4	AntigensIBA 10/2014 - 11/2010
4	taxaneIBA 05/2014 - 11/2010
3	Pharmaceutical PreparationsIBA 10/2015 - 09/2011
3	epothilone B (EPO906)IBA 12/2012 - 11/2010
2	PlatinumIBA 10/2021 - 06/2009
2	Biological ProductsIBA 02/2021 - 05/2014
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2018 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 02/2016 - 10/2014
2	Indicators and Reagents (Reagents)IBA 01/2016 - 11/2015
2	Taxoids (Taxanes)IBA 05/2014 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2013 - 09/2011
2	Testosterone (Sustanon)FDA Link 01/2013 - 01/2009
2	Epothilones (Epothilone)IBA 12/2012 - 01/2012
1	tivozanibIBA 10/2021
1	GadoliniumIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Protein Disulfide-IsomerasesIBA 05/2018
1	Estrogen ReceptorsIBA 01/2018
1	ChromatinIBA 11/2017
1	Bevacizumab (Avastin)FDA Link 04/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2017
1	P-2 (P 2)IBA 12/2016
1	Carcinoembryonic AntigenIBA 10/2014
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 10/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2014
1	discodermolideIBA 04/2013
1	A-factor (Streptomyces)IBA 02/2013
1	MicroRNAs (MicroRNA)IBA 02/2013
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 12/2012
1	Androgen Antagonists (Antiandrogens)IBA 05/2012
1	AndrogensIBA 05/2012
1	AdrenomedullinIBA 01/2012
1	Chromogranin AIBA 10/2011
1	Octreotide (Sandostatin)FDA LinkGeneric 10/2011
1	Vinblastine (Vinblastine Sulfate)FDA Link 09/2011
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 09/2011
1	CytokinesIBA 09/2011
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2011

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2019 - 06/2009
9	Hysterectomy 01/2019 - 03/2007
6	Radiotherapy 01/2019 - 05/2009
6	Lymph Node Excision (Lymph Node Dissection) 11/2017 - 11/2015
5	Therapeutics 02/2021 - 05/2002
5	Adjuvant Chemotherapy 03/2018 - 07/2014
3	Brachytherapy 11/2017 - 04/2017
2	Minimally Invasive Surgical Procedures 11/2018 - 07/2014
2	Laparotomy 11/2018 - 07/2014
2	Adjuvant Radiotherapy 11/2017 - 12/2016
2	Pelvic Exenteration 01/2017 - 12/2016
1	Precision Medicine 01/2019
1	Cytoreduction Surgical Procedures 01/2018
1	Mastectomy (Mammectomy) 01/2018
1	Segmental Mastectomy (Lumpectomy) 01/2018
1	Neoadjuvant Therapy 10/2017
1	Ovariectomy (Oophorectomy) 04/2017
1	Operative Surgical Procedures 12/2016
1	Salpingo-oophorectomy 11/2015
1	Palliative Care (Palliative Therapy) 10/2015
1	Endometrial Ablation Techniques 05/2015
1	Castration 01/2015